ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)
Epistemonikos ID: a504b405099d0013c4ff678c265b1f6045a0e7db
First added on: Feb 19, 2024